Acceptability of 'as needed' biologic therapy in psoriasis: insights from a multi-stakeholder mixed methods study

CONCLUSION: These data indicate that 'as needed' biologic therapy in psoriasis is acceptable for both patients and clinicians. Formal assessment of clinical effectiveness and cost effectiveness is warranted, to enable the real-world potential of this approach to be realised.PMID:38366988 | DOI:10.1093/bjd/ljae068
Source: The British Journal of Dermatology - Category: Dermatology Authors: Source Type: research